Prosthetic Heart Valve Market By Product (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve): Global Opportunity Analysis and Industry Forecast, 2024-2035
The prosthetic heart valve market was valued at $8.6 billion in 2023 and is projected to reach $30.3 billion by 2035, registering a CAGR of 11.1% from 2024 to 2035. Prosthetic heart valves serve as synthetic replacements for damaged or diseased heart valves, crucial components that regulate blood flow in and out of the heart's chambers. Dysfunction in these valves can lead to a spectrum of cardiovascular issues, including shortness of breath, fatigue, chest pain, and even heart failure. Designed to mimic the functionality of healthy heart valves, prosthetic heart valves facilitate proper blood circulation throughout the body. The primary types of prosthetic heart valves are mechanical heart valves, tissue heart valves, and transcatheter heart valves.
The growth of the prosthetic heart valve market is primarily driven by increasing prevalence of heart valve diseases, technological advancements in heart valves, and increase in demand for minimally invasive procedures. For instance, according to American College of Cardiology 2021, more than 5 million people are diagnosed with valvular heart diseases (VHD) each year in the U.S. Thus, rise in prevalence of valvular heart diseases (VHD) drives the market growth. In addition, surge in demand for minimally invasive procedures, propelling the adoption of transcatheter heart valve replacement. This approach, highlighted for its reduced invasiveness and quicker recovery, has become increasingly favored over traditional open-heart surgery, driving market growth. Furthermore, a rise in the number of heart valve surgeries across the world is expected to boost the growth of the prosthetic heart valve market. For instance, an article published by National Library of Medicine in 2022, 200,000 heart valve replacement surgeries are performed annually worldwide, and is expected to increase to 8,50,000 by 2050, Thus, rise in number of heart valve surgeries results in demand for prosthetic heart valve and fuels the market growth. The aging of the population is a global phenomenon, and this demographic shift is expected to continue to drive demand for these prosthetic heart valve devices during the forecast period. This increase in cardiac disorders drives the demand for prosthetic heart valves, which are used to treat a range of heart valve diseases, including aortic stenosis, mitral stenosis, and mitral regurgitation. In addition to the surge in prevalence of cardiac disorders and the aging of the population, the prosthetic heart valve market is being driven by increased patient awareness. Patients have become more informed about their health and the available treatment options, and this is leading to increased demand for prosthetic heart valves as a safe and effective treatment option for heart valve diseases. Moreover, increased government initiatives and awareness regarding heart valve diseases foster the growth of the market. Governments around the world invest in R&D of new treatments for heart valve diseases, which has led to the development of advanced prosthetic heart valve devices. In addition, rise in awareness about the symptoms and risk factors associated with heart valve disease have led to more people seeking medical treatment for the condition, which has further driven the growth of the market. The prosthetic heart valve market is segmented on the basis of product and region. By product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). Major key players that operate in the global prosthetic heart valve market are Abbott Laboratories, Boston Scientific Corporation, ShockWave Medical, Inc., Edward Lifesciences Corporation, Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., Labcor Laboratorios Ltda, Artivion, Inc, and JenaValve Technology, Inc. The key players operating in the market have adopted agreement, product launch, product approval, and rebranding as their key strategies to expand their product portfolio
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the prosthetic heart valve market analysis from 2023 to 2035 to identify the prevailing prosthetic heart valve market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the prosthetic heart valve market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global prosthetic heart valve market trends, key players, market segments, application areas, and market growth strategies.
Regulatory Guidelines
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
Tissue Heart Valve
Type
Stented Tissue Heart Valve
Stentless Tissue Heart Valve
Mechanical Heart Valve
Transcatheter Heart Valve
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Meril Life Sciences Pvt. Ltd.
Abbott Laboratories
Labcor Laboratorios Ltda
Artivion, Inc.
Boston Scientific Corporation
LivaNova PLC
Edwards Lifesciences Corporation
ShockWave Medical, Inc.
Medtronic plc
JenaValve Technology, Inc.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: PROSTHETIC HEART VALVE MARKET, BY PRODUCT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Mechanical Heart Valve
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Tissue Heart Valve
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Tissue Heart Valve Prosthetic Heart Valve Market by Type
- 4.4. Transcatheter Heart Valve
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: PROSTHETIC HEART VALVE MARKET, BY REGION
- 5.1. Overview
- 5.1.1. Market size and forecast By Region
- 5.2. North America
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by Product
- 5.2.3. Market size and forecast, by country
- 5.2.3.1. U.S.
- 5.2.3.1.1. Market size and forecast, by Product
- 5.2.3.2. Canada
- 5.2.3.2.1. Market size and forecast, by Product
- 5.2.3.3. Mexico
- 5.2.3.3.1. Market size and forecast, by Product
- 5.3. Europe
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by Product
- 5.3.3. Market size and forecast, by country
- 5.3.3.1. Germany
- 5.3.3.1.1. Market size and forecast, by Product
- 5.3.3.2. France
- 5.3.3.2.1. Market size and forecast, by Product
- 5.3.3.3. UK
- 5.3.3.3.1. Market size and forecast, by Product
- 5.3.3.4. Italy
- 5.3.3.4.1. Market size and forecast, by Product
- 5.3.3.5. Spain
- 5.3.3.5.1. Market size and forecast, by Product
- 5.3.3.6. Rest of Europe
- 5.3.3.6.1. Market size and forecast, by Product
- 5.4. Asia-Pacific
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by Product
- 5.4.3. Market size and forecast, by country
- 5.4.3.1. Japan
- 5.4.3.1.1. Market size and forecast, by Product
- 5.4.3.2. China
- 5.4.3.2.1. Market size and forecast, by Product
- 5.4.3.3. India
- 5.4.3.3.1. Market size and forecast, by Product
- 5.4.3.4. Australia
- 5.4.3.4.1. Market size and forecast, by Product
- 5.4.3.5. South Korea
- 5.4.3.5.1. Market size and forecast, by Product
- 5.4.3.6. Rest of Asia-Pacific
- 5.4.3.6.1. Market size and forecast, by Product
- 5.5. LAMEA
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by Product
- 5.5.3. Market size and forecast, by country
- 5.5.3.1. Brazil
- 5.5.3.1.1. Market size and forecast, by Product
- 5.5.3.2. Saudi Arabia
- 5.5.3.2.1. Market size and forecast, by Product
- 5.5.3.3. South Africa
- 5.5.3.3.1. Market size and forecast, by Product
- 5.5.3.4. Rest of LAMEA
- 5.5.3.4.1. Market size and forecast, by Product
- CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top winning strategies
- 6.3. Product mapping of top 10 player
- 6.4. Competitive dashboard
- 6.5. Competitive heatmap
- 6.6. Top player positioning, 2023
- CHAPTER 7: COMPANY PROFILES
- 7.1. Meril Life Sciences Pvt. Ltd.
- 7.1.1. Company overview
- 7.1.2. Key executives
- 7.1.3. Company snapshot
- 7.1.4. Operating business segments
- 7.1.5. Product portfolio
- 7.1.6. Business performance
- 7.1.7. Key strategic moves and developments
- 7.2. Abbott Laboratories
- 7.2.1. Company overview
- 7.2.2. Key executives
- 7.2.3. Company snapshot
- 7.2.4. Operating business segments
- 7.2.5. Product portfolio
- 7.2.6. Business performance
- 7.2.7. Key strategic moves and developments
- 7.3. Labcor Laboratorios Ltda
- 7.3.1. Company overview
- 7.3.2. Key executives
- 7.3.3. Company snapshot
- 7.3.4. Operating business segments
- 7.3.5. Product portfolio
- 7.3.6. Business performance
- 7.3.7. Key strategic moves and developments
- 7.4. Artivion, Inc.
- 7.4.1. Company overview
- 7.4.2. Key executives
- 7.4.3. Company snapshot
- 7.4.4. Operating business segments
- 7.4.5. Product portfolio
- 7.4.6. Business performance
- 7.4.7. Key strategic moves and developments
- 7.5. Boston Scientific Corporation
- 7.5.1. Company overview
- 7.5.2. Key executives
- 7.5.3. Company snapshot
- 7.5.4. Operating business segments
- 7.5.5. Product portfolio
- 7.5.6. Business performance
- 7.5.7. Key strategic moves and developments
- 7.6. LivaNova PLC
- 7.6.1. Company overview
- 7.6.2. Key executives
- 7.6.3. Company snapshot
- 7.6.4. Operating business segments
- 7.6.5. Product portfolio
- 7.6.6. Business performance
- 7.6.7. Key strategic moves and developments
- 7.7. Edwards Lifesciences Corporation
- 7.7.1. Company overview
- 7.7.2. Key executives
- 7.7.3. Company snapshot
- 7.7.4. Operating business segments
- 7.7.5. Product portfolio
- 7.7.6. Business performance
- 7.7.7. Key strategic moves and developments
- 7.8. ShockWave Medical, Inc.
- 7.8.1. Company overview
- 7.8.2. Key executives
- 7.8.3. Company snapshot
- 7.8.4. Operating business segments
- 7.8.5. Product portfolio
- 7.8.6. Business performance
- 7.8.7. Key strategic moves and developments
- 7.9. Medtronic plc
- 7.9.1. Company overview
- 7.9.2. Key executives
- 7.9.3. Company snapshot
- 7.9.4. Operating business segments
- 7.9.5. Product portfolio
- 7.9.6. Business performance
- 7.9.7. Key strategic moves and developments
- 7.10. JenaValve Technology, Inc.
- 7.10.1. Company overview
- 7.10.2. Key executives
- 7.10.3. Company snapshot
- 7.10.4. Operating business segments
- 7.10.5. Product portfolio
- 7.10.6. Business performance
- 7.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 02. PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY REGION, 2023-2035 ($MILLION)
- TABLE 03. PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY REGION, 2023-2035 ($MILLION)
- TABLE 04. GLOBAL TISSUE HEART VALVE PROSTHETIC HEART VALVE MARKET, BY TYPE, 2023-2035 ($MILLION)
- TABLE 05. PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY REGION, 2023-2035 ($MILLION)
- TABLE 06. PROSTHETIC HEART VALVE MARKET, BY REGION, 2023-2035 ($MILLION)
- TABLE 07. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 08. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 09. U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 10. CANADA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 11. MEXICO PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 12. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 13. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 14. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 15. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 16. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 17. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 18. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 19. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 20. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 21. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 22. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 23. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 24. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 25. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 26. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 27. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 28. LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 29. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
- TABLE 30. BRAZIL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 31. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 32. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 33. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
- TABLE 34. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
- TABLE 35. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
- TABLE 36. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT SEGMENTS
- TABLE 37. MERIL LIFE SCIENCES PVT. LTD.: SERVICE SEGMENTS
- TABLE 38. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
- TABLE 39. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIES
- TABLE 40. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 41. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 42. ABBOTT LABORATORIES: PRODUCT SEGMENTS
- TABLE 43. ABBOTT LABORATORIES: SERVICE SEGMENTS
- TABLE 44. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 45. ABBOTT LABORATORIES: KEY STRATEGIES
- TABLE 46. LABCOR LABORATORIOS LTDA: KEY EXECUTIVES
- TABLE 47. LABCOR LABORATORIOS LTDA: COMPANY SNAPSHOT
- TABLE 48. LABCOR LABORATORIOS LTDA: PRODUCT SEGMENTS
- TABLE 49. LABCOR LABORATORIOS LTDA: SERVICE SEGMENTS
- TABLE 50. LABCOR LABORATORIOS LTDA: PRODUCT PORTFOLIO
- TABLE 51. LABCOR LABORATORIOS LTDA: KEY STRATEGIES
- TABLE 52. ARTIVION, INC.: KEY EXECUTIVES
- TABLE 53. ARTIVION, INC.: COMPANY SNAPSHOT
- TABLE 54. ARTIVION, INC.: PRODUCT SEGMENTS
- TABLE 55. ARTIVION, INC.: SERVICE SEGMENTS
- TABLE 56. ARTIVION, INC.: PRODUCT PORTFOLIO
- TABLE 57. ARTIVION, INC.: KEY STRATEGIES
- TABLE 58. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 59. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 60. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
- TABLE 61. BOSTON SCIENTIFIC CORPORATION: SERVICE SEGMENTS
- TABLE 62. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 63. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIES
- TABLE 64. LIVANOVA PLC: KEY EXECUTIVES
- TABLE 65. LIVANOVA PLC: COMPANY SNAPSHOT
- TABLE 66. LIVANOVA PLC: PRODUCT SEGMENTS
- TABLE 67. LIVANOVA PLC: SERVICE SEGMENTS
- TABLE 68. LIVANOVA PLC: PRODUCT PORTFOLIO
- TABLE 69. LIVANOVA PLC: KEY STRATEGIES
- TABLE 70. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
- TABLE 71. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 72. EDWARDS LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
- TABLE 73. EDWARDS LIFESCIENCES CORPORATION: SERVICE SEGMENTS
- TABLE 74. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 75. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIES
- TABLE 76. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
- TABLE 77. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
- TABLE 78. SHOCKWAVE MEDICAL, INC.: PRODUCT SEGMENTS
- TABLE 79. SHOCKWAVE MEDICAL, INC.: SERVICE SEGMENTS
- TABLE 80. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
- TABLE 81. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIES
- TABLE 82. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 83. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 84. MEDTRONIC PLC: PRODUCT SEGMENTS
- TABLE 85. MEDTRONIC PLC: SERVICE SEGMENTS
- TABLE 86. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 87. MEDTRONIC PLC: KEY STRATEGIES
- TABLE 88. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
- TABLE 89. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
- TABLE 90. JENAVALVE TECHNOLOGY, INC.: PRODUCT SEGMENTS
- TABLE 91. JENAVALVE TECHNOLOGY, INC.: SERVICE SEGMENTS
- TABLE 92. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
- TABLE 93. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIES
- LIST OF FIGURES
- FIGURE 01. PROSTHETIC HEART VALVE MARKET, 2023-2035
- FIGURE 02. SEGMENTATION OF PROSTHETIC HEART VALVE MARKET,2023-2035
- FIGURE 03. TOP IMPACTING FACTORS IN PROSTHETIC HEART VALVE MARKET
- FIGURE 04. TOP INVESTMENT POCKETS IN PROSTHETIC HEART VALVE MARKET (2024-2035)
- FIGURE 05. BARGAINING POWER OF SUPPLIERS
- FIGURE 06. BARGAINING POWER OF BUYERS
- FIGURE 07. THREAT OF SUBSTITUTION
- FIGURE 08. THREAT OF SUBSTITUTION
- FIGURE 09. COMPETITIVE RIVALRY
- FIGURE 10. GLOBAL PROSTHETIC HEART VALVE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023 AND 2035(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY 2023 AND 2035(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY 2023 AND 2035(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY 2023 AND 2035(%)
- FIGURE 15. PROSTHETIC HEART VALVE MARKET BY REGION, 2023 AND 2035(%)
- FIGURE 16. U.S. PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 17. CANADA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 18. MEXICO PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 19. GERMANY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 20. FRANCE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 21. UK PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 22. ITALY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 23. SPAIN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 24. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 25. JAPAN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 26. CHINA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 27. INDIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 28. AUSTRALIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 29. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 30. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 31. BRAZIL PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 32. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 33. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 34. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
- FIGURE 35. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 38. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 39. COMPETITIVE DASHBOARD
- FIGURE 40. COMPETITIVE HEATMAP: PROSTHETIC HEART VALVE MARKET
- FIGURE 41. TOP PLAYER POSITIONING, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook